AAAAAA
Results:
1-7
|
Results: 7
Authors:
Samlowski, WE
Gundacker, H
Kuebler, JP
Giguere, JK
Mills, GM
Schuller, DE
Ensley, JF
Citation: We. Samlowski et al., Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group Phase II study, INV NEW DR, 19(4), 2001, pp. 311-315
Authors:
Samlowski, WE
Citation: We. Samlowski, Nitric oxide as a mediator of interleukin-2 induced cardiovascular toxicity and antitumor activity, PROG INFLAM, 2001, pp. 249-272
Authors:
Maheshwari, A
Mahato, RI
McGregor, J
Han, SO
Samlowski, WE
Park, JS
Kim, SW
Citation: A. Maheshwari et al., Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment, MOL THER, 2(2), 2000, pp. 121-130
Authors:
Schlegel, PJ
Samlowski, WE
Ward, JH
Citation: Pj. Schlegel et al., Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemiaand renal cell carcinoma after treatment with high-dose intravenous bolus interleukin-2, J IMMUNOTH, 23(4), 2000, pp. 507-508
Authors:
Kwak, JY
Han, MK
Choi, KS
Park, IH
Park, SY
Sohn, MH
Kim, UH
McGregor, JR
Samlowski, WE
Yim, CY
Citation: Jy. Kwak et al., Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells, CELL IMMUN, 203(2), 2000, pp. 84-94
Authors:
Grosset, AB
McGregor, JR
Samlowski, WE
Rodgers, GM
Citation: Ab. Grosset et al., Immunosuppressive effects of factor IX products: an in vitro study, HAEMOPHILIA, 5(6), 1999, pp. 416-425
Authors:
Karanes, C
Kopecky, KJ
Head, DR
Grever, MR
Hynes, HE
Kraut, EH
Vial, RH
Lichtin, A
Nand, S
Samlowski, WE
Appelbaum, FR
Citation: C. Karanes et al., A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia, LEUK RES, 23(9), 1999, pp. 787-794
Risultati:
1-7
|